Abstract
Despite the discovery of protein histidine (His) phosphorylation nearly six decades ago, difficulties in measuring and quantifying this unstable post-translational modification (PTM) have limited its mechanistic analysis in prokaryotic and eukaryotic signaling. Here, we describe reliable procedures for affinity purification, cofactor-binding analysis and antibody-based detection of phosphohistidine (pHis), on the putative human His kinases NME1 (NDPK-A) and NME2 (NDPK-B) and the glycolytic phosphoglycerate mutase PGAM1. By exploiting isomer-specific monoclonal N1-pHis and N3-pHis antibodies, we describe robust protocols for immunological detection and isomer discrimination of site-specific pHis, including N3-pHis on His 11 of PGAM1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hunter T (2012) Why nature chose phosphate to modify proteins. Philos Trans R Soc Lond Ser B Biol Sci 367:2513–2516
Cohen P (2002) The origins of protein phosphorylation. Nat Cell Biol 4:E127–E130
Haydon CE, Eyers PA, Aveline-Wolf LD et al (2003) Identification of novel phosphorylation sites on Xenopus laevis Aurora A and analysis of phosphopeptide enrichment by immobilized metal-affinity chromatography. Mol Cell Proteomics 2:1055–1067
Schweppe RE, Haydon CE, Lewis TS et al (2003) The characterization of protein post-translational modifications by mass spectrometry. Acc Chem Res 36:453–461
Fuhs SR, Meisenhelder J, Aslanian A et al (2015) Monoclonal 1- and 3-phosphohistidine antibodies: new tools to study histidine phosphorylation. Cell 162:198–210
Kee JM, Oslund RC, Perlman DH et al (2013) A pan-specific antibody for direct detection of protein histidine phosphorylation. Nat Chem Biol 9:416–421
Hardman G et al. (2017) Extensive non-canonical phosphorylation in human cells revealed using strong-anion exchange-mediated phosphoproteomics. bioRxiv. doi: 10.1101/202820
Boyer PD, Deluca M, Ebner KE et al (1962) Identification of phosphohistidine in digests from a probable intermediate of oxidative phosphorylation. J Biol Chem 237:PC3306–PC3308
Kee JM, Muir TW (2012) Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family. ACS Chem Biol 7:44–51
Puttick J, Baker EN, Delbaere LT (2008) Histidine phosphorylation in biological systems. Biochim Biophys Acta 1784:100–105
Olsen JV, Blagoev B, Gnad F et al (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635–648
Chen Y, Gallois-Montbrun S, Schneider B et al (2003) Nucleotide binding to nucleoside diphosphate kinases: X-ray structure of human NDPK-A in complex with ADP and comparison to protein kinases. J Mol Biol 332:915–926
Srivastava S, Panda S, Li Z et al (2016) Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1. elife 5:pii: e16093
Attwood PV, Muimo R (2018) The actions of NME1/NDPK-A and NME2/NDPK-B as protein kinases. Lab Investig 98:283–290
Attwood PV, Wieland T (2015) Nucleoside diphosphate kinase as protein histidine kinase. Naunyn Schmiedeberg's Arch Pharmacol 388:153–160
Vander Heiden MG, Locasale JW, Swanson KD et al (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329:1492–1499
Panda S, Srivastava S, Li Z et al (2016) Identification of PGAM5 as a mammalian protein histidine phosphatase that plays a central role to negatively regulate CD4(+) T cells. Mol Cell 63:457–469
Byrne DP, Li Y, Ngamlert P et al (2018) New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors. Biochem J 475:2435–2455
Green R, Rogers EJ (2013) Transformation of chemically competent E. coli. Methods Enzymol 529:329–336
Byrne DP, Vonderach M, Ferries S et al (2016) cAMP-dependent protein kinase (PKA) complexes probed by complementary differential scanning fluorimetry and ion mobility-mass spectrometry. Biochem J 473:3159–3175
Scutt PJ, Chu ML, Sloane DA et al (2009) Discovery and exploitation of inhibitor-resistant aurora and polo kinase mutants for the analysis of mitotic networks. J Biol Chem 284:15880–15893
Foulkes DM, Byrne DP, Yeung W et al (2018) Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells. Sci Signal 11:pii: eaat7951
Murphy JM, Zhang Q, Young SN et al (2014) A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties. Biochem J 457:323–334
Mohanty S, Oruganty K, Kwon A et al (2016) Hydrophobic core variations provide a structural framework for tyrosine kinase evolution and functional specialization. PLoS Genet 12:e1005885
Rudolf AF, Skovgaard T, Knapp S et al (2014) A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination. PLoS One 9:e98800
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Clubbs Coldron, A.K.M., Byrne, D.P., Eyers, P.A. (2020). Analysis of 1- and 3-Phosphohistidine (pHis) Protein Modification Using Model Enzymes Expressed in Bacteria. In: Eyers, C. (eds) Histidine Phosphorylation. Methods in Molecular Biology, vol 2077. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9884-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9884-5_5
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9883-8
Online ISBN: 978-1-4939-9884-5
eBook Packages: Springer Protocols